Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
3,993,298
-
Shares change
-
+1,187,753
-
Total reported value, excl. options
-
$14,891,858
-
Value change
-
+$4,430,787
-
Put/Call ratio
-
508%
-
Number of buys
-
16
-
Number of sells
-
-9
-
Price
-
$3.73
Significant Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q4 2021
41 filings reported holding DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value as of Q4 2021.
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,993,298 shares
of 51,654,406 outstanding shares and own 7.73% of the company stock.
Largest 10 shareholders include Stonepine Capital Management, LLC (1,194,670 shares), VANGUARD GROUP INC (786,552 shares), COOPERMAN LEON G (300,000 shares), JACOB ASSET MANAGEMENT OF NEW YORK LLC (275,000 shares), Ikarian Capital, LLC (209,082 shares), GEODE CAPITAL MANAGEMENT, LLC (167,763 shares), Manatuck Hill Partners, LLC (144,800 shares), TWO SIGMA INVESTMENTS, LP (140,857 shares), Anson Funds Management LP (130,070 shares), and TWO SIGMA ADVISERS, LP (106,600 shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.